EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.7.11.13 | Sarcoma, Avian |
52872 |
Protein kinase and its regulatory effect on reverse transcriptase activity of Rous sarcoma virus. |
ongoing research therapeutic application unassigned |
3 1 0 |
2.7.11.13 | Infections |
170098 |
Protein kinase of bacteriophage T7. 1. Purification. |
therapeutic application unassigned |
1 0 |
2.7.11.13 | Lymphoma |
191831 |
Subunit interaction in cyclic AMP-dependent protein kinase of mutant lymphoma cells. |
ongoing research therapeutic application unassigned |
4 1 0 |
2.7.11.13 | Plasmacytoma |
192298 |
Resolution and general properties of different types of ribosomal protein kinases in mouse plasmocytoma. |
ongoing research therapeutic application unassigned |
2 1 0 |
2.7.11.13 | Lymphoma |
193571 |
Altered regulation of cyclic AMP-dependent protein kinase in a mouse lymphoma cell line. |
ongoing research unassigned |
4 0 |
2.7.11.13 | Infections |
1101258 |
In vivo and in vitro phosphorylation of DNA-dependent RNA polymerase of Escherichia coli by bacteriophage-T7-induced protein kinase. |
unassigned |
0 |
2.7.11.13 | Cholera |
1280118 |
Calcitonin gene-related peptide stimulates intracellular cAMP via a protein kinase C-controlled mechanism in human ocular ciliary epithelial cells. |
therapeutic application unassigned |
1 0 |
2.7.11.13 | Endometrial Neoplasms |
1280205 |
Phorbol esters differentially regulate the expression of insulin-like growth factor-binding proteins in endometrial carcinoma cells. |
ongoing research unassigned |
4 0 |
2.7.11.13 | Neoplasms |
1280235 |
Pituitary adenylate cyclase polypeptide (PACAP) stimulates cyclic AMP formation in pituitary fibroblasts and 3T3 tumor fibroblasts: lack of enhancement by protein kinase C activation. |
causal interaction ongoing research unassigned |
4 4 0 |
2.7.11.13 | Herpes Zoster |
1280321 |
Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidences for receptor regulation. |
causal interaction ongoing research therapeutic application unassigned |
3 1 1 0 |